Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.53 USD | -0.43% |
|
-0.82% | -3.77% |
Feb. 14 | US FDA approves GSK's combo meningococcal vaccine | RE |
Feb. 14 | Pfizer Insider Bought Shares Worth $499,072, According to a Recent SEC Filing | MT |
P/E ratio (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Yield (Y) | Capi.($) | ||
---|---|---|---|---|---|---|---|---|---|
15x | 1.63x | 0.04x | 3.22x | 8.11x | 9.86x | 6.53% | 145B | ||
68.58x | 45.32x | 0.61x | 17.35x | 48.49x | 55.11x | 0.62% | 760B | ||
18.58x | 5.02x | 0.41x | 4.19x | 11.31x | 12.78x | 3.23% | 376B | ||
20.38x | 12.01x | 0.97x | 7.17x | 14.05x | 15.42x | 2.43% | 349B | ||
25.85x | 38.95x | 0.12x | 6.62x | 13.64x | 14.06x | 3.39% | 340B | ||
15.6x | 5.95x | 0.19x | 3.81x | 9.42x | 10.76x | 3.37% | 264B | ||
27.69x | 5.54x | 0.69x | 4.71x | 14.87x | 14.76x | 2.1% | 229B | ||
11.85x | 4.47x | 0x | 3.63x | 8.72x | 9.85x | 3.7% | 210B | ||
16.58x | 4.67x | 2.02x | 4.16x | 10.06x | 10.92x | 3.64% | 210B | ||
25.44x | 22.45x | 0.5x | 5.74x | 11.07x | 12.95x | 3.3% | 156B | ||
13.35x | 1.6x | 0.19x | 2.85x | 9.41x | 10.01x | 3.94% | 137B | ||
1025.62x | 6.83x | -10.49x | 5.21x | 13.92x | 17.91x | 2.94% | 130B | ||
12.14x | 5.35x | -0.06x | 3.07x | 8.07x | 8.39x | 4.56% | 109B | ||
30.45x | 6.4x | 1.49x | 9.6x | 19.27x | 20.54x | 1.24% | 78.46B | ||
16.92x | 3.97x | -0.56x | 2.33x | 7.17x | 8.06x | 4.2% | 73.85B | ||
29.15x | 3.92x | 1.5x | 3.28x | 17.97x | 21.34x | 1.65% | 45.05B | ||
23.46x | 2.07x | 0.52x | 3.8x | 15.26x | 16.94x | 1.61% | 43.88B | ||
51.06x | 0.91x | -4.36x | 2.34x | 9.55x | 30.68x | 4.72% | 43.27B | ||
48.21x | 6.41x | 1.24x | 9.79x | 38.47x | 40.84x | 0.51% | 39.89B | ||
Average | 78.73x | 9.66x | -0.26x | 5.42x | 15.20x | 17.96x | percentage-no-prefix | 196.77B | |
Weighted average by Cap. | 65.24x | 17.48x | 0.11x | 7.42x | 19.48x | 22.03x | percentage-no-prefix |
- Stock Market
- Equities
- PFE Stock
- Sector Pfizer, Inc.
- Sector valuations